Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Journal of Cellular and Molecular Medicine|November 18, 2021
Pharmacological inhibition of Carbonic Anhydrase IX and XII to enhance targeting of acute myeloid leukaemia cells under hypoxic conditionsFangli Chen, Emilia Licarete, Xue Wu, et al.
Nature Communications|September 29, 2025
Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumorsRen-Yuan Bai, Jingyi Shi, Jianan Liu, et al.
Molecular Oncology|November 16, 2023
Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progressionNayela N Chowdhury, Yi Yang, Ananya Dutta, et al.
Genes & Diseases|April 4, 2023
Inhibition of PRMT5 by market drugs as a novel cancer therapeutic avenueLakshmi Prabhu, Matthew Martin, Lan Chen, et al.
Cancers|December 23, 2022
Drug Inhibition of Redox Factor-1 Restores Hypoxia-Driven Changes in Tuberous Sclerosis Complex 2 Deficient CellsJesse D Champion, Kayleigh M Dodd, Hilaire C Lam, et al.
Journal of Cellular and Molecular Medicine|December 4, 2020
Combined inhibition of Ref-1 and STAT3 leads to synergistic tumour inhibition in multiple cancers using 3D and in vivo tumour co-culture modelsRachel A Caston, Fenil Shah, Colton L Starcher, et al.
British Journal of Cancer|March 4, 2021
Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumoursSilpa Gampala, Fenil Shah, Chi Zhang, et al.
Journal of Medicinal Chemistry|February 19, 2019
Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic CancerAndrew E Shouksmith, Fenil Shah, Michelle L Grimard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2023
Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor ProgressionDana K Mitchell, Breanne Burgess, Emily E White, et al.
Pharmacological Research|February 4, 2024
New Ref-1/APE1 targeted inhibitors demonstrating improved potency for clinical applications in multiple cancer typesSilpa Gampala, Hye-Ran Moon, Randall Wireman, et al.
Pageof 9